During the past decade, Genesee Cancer and Blood Disease Treatment Center conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 32 clinical trials were completed, i.e. on average, 26.2% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 31 clinical trials were completed. i.e. 77.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genesee Cancer and Blood Disease Treatment Center" #1 sponsor was "National Cancer Institute (NCI)" with 67 trials, followed by "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "SWOG Cancer Research Network" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesee Cancer and Blood Disease Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 78 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Genesee Cancer and Blood Disease Treatment Center" are "Stage IV Lung Cancer AJCC v8" (12 trials), "Stage IVA Lung Cancer AJCC v8" (9 trials), "Stage IVB Lung Cancer AJCC v8" (9 trials), "Recurrent Lung Non-Small Cell Carcinoma" (8 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "Genesee Cancer and Blood Disease Treatment Center" in a lesser frequency.

Most popular intervention types in "Genesee Cancer and Blood Disease Treatment Center" are "Drug" (117 trials), "Other" (83 trials), "Biological" (55 trials), "Procedure" (41 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (43 trials), "Questionnaire Administration" (30 trials), "Laboratory Biomarker Analysis" (28 trials), "Computed Tomography" (27 trials) and "Biospecimen Collection" (26 trials). Other intervention names were less common.

The vast majority of trials in "Genesee Cancer and Blood Disease Treatment Center" are 126 trials for "All" genders, 18 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Genesee Cancer and Blood Disease Treatment Center". undefined are not yet recruiting, 58 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Genesee Cancer and Blood Disease Treatment Center, 6 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Genesee Cancer and Blood Disease Treatment Center, 2 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".